Studies Highlight Tools for Diagnosis of COPD

Share this content:
Studies Highlight Tools for Diagnosis of COPD
Studies Highlight Tools for Diagnosis of COPD

(HealthDay News) -- Two studies published in the January/February issue of the Annals of Family Medicine evaluate the tools available for diagnosis of chronic obstructive pulmonary disease (COPD).

In the first study, Wouter van Dijk, M.D., Ph.D., from Radboud University in Nijmegen, Netherlands, and colleagues compared the clinical relevance of two criteria (the fixed ratio and the lower limit of normal) for defining a low ratio of forced expiratory volume in one second (FEV1) to forced vital capacity. Data were analyzed for 4,882 patients aged 40 years and older. The researchers found that the prevalence of airflow limitation was 17 and 11 percent by fixed ratio and lower limit of normal, respectively. The strongest increases in odds of adverse outcomes were seen for patients with airflow limitation based on both fixed ratio and lower limit of normal and with low FEV1.

In the second study, Verónica Casado, M.D., Ph.D., from the Parquesol Teaching Health Center in Valladolid, Spain, and colleagues conducted a cross-sectional study involving 233 adults aged 40 to 75 years to examine laryngeal height, lung function, and diagnostic questionnaires as diagnostic tools for COPD. The researchers observed a positive likelihood ratio of 5.21 for laryngeal height and a negative likelihood ratio of 0.10 for the Lung Function Questionnaire. The positive and negative likelihood ratios were 29.06 and 0.26, respectively, for combining the maximum laryngeal height of ≥4 cm with Lung Function Questionnaire findings of ≤18.

"Combining Lung Function Questionnaire results and laryngeal height can help confirm or dismiss COPD," Casado and colleagues write.

The van Dijk study was partially funded by pharmaceutical companies.

Abstract - van Dijk
Full Text
Abstract - Casado
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »